• SENSEX 80,567.71
    409.83 (+0.51%)
  • BANKNIFTY 54,067.55
    406.55 (+0.76%)
  • Ola Electric
    70.25 123.90(%)
  • N S D L
    1,236.20 880.00(%)
  • Aditya Vision
    447.00 328.25(%)
  • Vimta Labs
    829.00 787.20(%)
  • One Mobikwik
    300.00 698.30(%)
  • Tata Steel
    168.00 170.20(%)
  • Netweb Technol.
    2,564.75 3,060.00(%)
  • Apollo Micro Sys
    306.60 298.70(%)
  • Aurobindo Pharma
    1,041.00 1,592.55(%)
  • Jai Corp
    170.15 406.00(%)
  • Moschip Tech.
    196.45 279.00(%)
  • Godfrey Phillips
    10,420.00 11,462.00(%)
  • Yes Bank
    20.38 24.40(%)
  • M & M
    3,292.60 3,430.10(%)
  • NTPC
    333.45 292.70(%)
  • TBO Tek
    1,609.20 2,000.00(%)
  • AU Small Finance
    716.05 840.95(%)
  • Larsen & Toubro
    3,606.35 3,963.00(%)
  • TCS
    3,087.75 2,992.05(%)
  • Bharat Electron
    381.05 435.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Everest Organics Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4614.0
  • ISIN : INE334C01029
385.00 0 (0.00%)
  • As on 03 Sep 2025 (EOD)

  • Today’s Low

    380.00

  • Today’s High

    389.95

  • Open

    389.95

  • Perv Close

    385.00

  • 52W Low

    112.50

  • 52W High

    477.00

Key Indicators

  • P/E(TTM)

    60.25

  • Mar.Cap (₹Cr.)

    373.86

  • Div & Yield %

    0.00

  • Book Value(₹)

    72.04

  • Debt-Equity Ratio

    0.00

  • AGM Date

    03-Sep-2025

  • EPS

    6.39

  • P/E Ratio

    60.25

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    373.86

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    9.71

  • BV (₹)

    72.00

  • Sales( ₹ in Cr.)

    159.48

  • NP (in Cr.)

    -1.29

  • NP Var(%)

    -1027.0

  • Div%

    0.0

  • CPS (₹)

    4.80

  • EPS (₹)

    -1.30

  • Traded Value (₹ in Lakhs)

    373.86

  • 52 Week High

    477.00

  • 52 Week Low

    112.50

  • Price BSE

    385.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    373.86

  • P/C Ratio

    80.00

  • P/E Ratio

    -289.70

  • Price Vs.BV

    -1.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 226.49 208.73 230.22 207.36 189.61 177.77
Excise Duty 29.25 25.69 30.17 25.79 22.40 21.92
Net Sales 197.24 183.04 200.05 181.57 167.21 155.85
Other Income 0.89 6.94 2.21 1.06 1.45 0.54
Stock Adjustments -0.56 3.23 4.51 8.22 5.78 2.15
Total Income 197.57 193.21 206.77 190.85 174.44 158.54
EXPENDITURE :            
Raw Materials 124.64 126.31 141.72 117.13 103.52 97.00
Power and Fuel Cost 15.40 18.88 14.70 12.36 11.85 10.81
Employee Cost 18.80 16.30 16.33 15.26 13.30 11.64
Other Manufacturing Expenses 15.37 13.66 15.80 13.91 14.60 12.64
Selling and Administration Expenses 10.52 9.75 8.66 7.65 7.34 6.33
Miscellaneous Expenses 0.96 0.44 0.92 0.64 3.10 1.75
Employee Benefit Expenses 18.80 16.30 16.33 15.26 13.30 11.64
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 185.69 185.35 198.13 166.94 153.71 140.17
Operating Profit 11.88 7.87 8.64 23.91 20.73 18.37
Interest 5.47 3.31 3.10 3.26 3.43 3.21
Gross Profit 6.41 4.56 5.54 20.65 17.30 15.16
Depreciation 5.80 4.47 3.80 3.37 3.21 2.84
Profit Before Tax 0.61 0.09 1.74 17.28 14.09 12.32
Current Tax 0.10 0.02 0.29 3.02 2.27 2.70
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.37 0.26 0.31 0.54 0.93 2.12
Reported Net Profit 0.14 -0.18 1.14 13.72 10.90 7.51
Extraordinary Items 0.00 -0.10 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.14 -0.08 1.14 13.72 10.90 7.51
Adjustment below Net Profit 0.00 0.00 -0.12 -0.14 -0.77 -0.22
P & L Balance brought forward 34.49 38.80 38.58 22.47 13.15 6.95
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.51 0.40 0.80 1.20 0.80 0.00
P & L Balance carried down 34.11 38.21 38.80 34.85 22.47 14.25
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 15.00 10.00 10.00
Dividend Per Share(Rs) 0.00 0.00 0.00 1.50 1.00 1.00
Earnings Per Share-Unit Curr 0.17 -0.23 1.43 17.14 13.62 9.39
Earnings Per Share(Adj)-Unit Curr 0.17 -0.23 1.43 17.14 13.62 9.39
Book Value 57.30 57.77 58.50 58.22 42.75 32.47
Book Value(Adj)-Unit Curr 57.30 57.77 58.50 58.22 42.75 32.47

Shareholding Pattern

  • Promoter Group

    60.78%

  • Public Share Holding

    39.22%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 169,128 169,128.00 169,128 169,128
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 169,128 1.74 169,128 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,725,546 38.37 3,725,546 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,783,641 18.37 1,783,641 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,732,903 59.04 5,732,903 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,214 0.02 2,214 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 36 0.00 36 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,250 0.02 2,250 3
2] Non Institution
Bodies Corporate 1,045,817 10.77 1,038,401 47
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 194,610 2.00 126,174 143
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 66,985 0.69 66,985 75
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,301,746 13.41 1,301,746 11
Individuals holding nominal share capital up to Rs. 1 lakh 1,180,411 12.16 930,967 7,989
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 13,248 0.14 13,248 1
Sub Total 3,806,245 39.20 3,480,949 8,269
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,710,526 100.00 9,385,230 8,281

Company Background

Everest Organics LtdPharmaceuticals - Indian - Bulk Drugs

  • Everest Organics Ltd
  • BSE Code : 4614.0
  • ISIN : INE334C01029

  • Incorporation Year

    1993

  • Registered Office

    Aroor Village
    Sadasivpet Mandal, Medak,
    Telangana-502291

  • Telephone

    91-8455-250113

  • FAX

    91-8455-250114

  • Chairman

  • Managing Director

  • Company Secretary

    Abdur Rahman

  • Auditor

    P S N Ravishanker & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Everest Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Everest Organics 385.00 198.13 226.49 60.25 5.94
Abbott India 32,356.30 6,684.73 6,409.15 47.34 44.95
Astrazeneca Phar 8,937.85 1,756.92 1,716.29 121.87 32.94
P & G Health Ltd 6,321.25 944.52 934.17 34.91 40.23
Glaxosmi. Pharma 2,749.15 3,866.05 3,723.49 49.44 58.72
Cipla 1,568.95 20,029.57 19,044.85 23.45 21.40
Amrutanjan Healt 729.20 469.50 451.82 38.66 21.89
Guj. Themis Bio. 376.95 152.47 150.80 92.16 27.21
Fermenta Biotec. 328.45 442.21 430.53 10.90 17.61
Bliss GVS Pharma 159.40 703.42 667.20 23.83 9.16
Ambalal Sarabhai 32.71 19.33 4.04 17.13 2.10